CJ Cheiljedang: Considering a Potential Sale of Its Bio Business
CJ Cheiljedang announced that it is considering on potentially selling its bio business for about 5-6 trillion won which could be more than its market cap.
CJ Cheiljedang's bio business is expected to have more than 4 trillion won in sales and about 700 billion won in EBITDA in 2024.
We are positive on the company's efforts to sell its Bio Business and reinvest it in its food business.
Keep reading with a 7-day free trial
Subscribe to Douglas Research Insights to keep reading this post and get 7 days of free access to the full post archives.